Successful treatment of recurrent epithelioid trophoblastic tumor (ETT) with pembrolizumab after pembrolizumab: A case report and review of literature in treatment of ETT
Sarah J Mokma, Sarah Alnaif, Nicholas Cardillo · 2026
Read Successful treatment of recurrent epithelioid trophoblastic tumor (ETT) with pembrolizumab after pembrolizumab: A case report and review of literature in treatment of ETT by Sarah J Mokma, Sarah Alnaif, Nicholas Cardillo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13628591.txt.
Description
Sarah Mokma, Sarah Alnaif, and Nicholas Cardillo told of a rare placental tumour case in 2026. Epithelioid trophoblastic tumours are very rare. Best treatment is therefore hard to define. Placental tissue carries a drug-target protein. Immune drugs may exploit that presence. A fifty-year-old patient had returning disease.
Pembrolizumab was used after earlier pembrolizumab treatment. Scans later showed no active disease signs. One year of upkeep passed cleanly. Imaging stayed free of body activity. The authors claim a first in past work here. Immune therapy followed immune therapy, and it worked, in this case. Late-stage disease data remain limited overall.
Catalog record
| CREATOR | Sarah J Mokma, Sarah Alnaif, Nicholas Cardillo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |